Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial

IMPORTANCE: Developmental and epileptic encephalopathies (DEEs) are the most severe group of drug-resistant epilepsies. Alternatives to oral therapies are urgently needed to reduce seizures and improve developmental outcomes and comorbidities in this medically complex population. OBJECTIVE: To asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheffer, Ingrid E., Hulihan, Joe, Messenheimer, John, Ali, Shayma, Keenan, Ngaire, Griesser, Jim, Gutterman, Donna L., Sebree, Terri, Sadleir, Lynette G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417764/
https://www.ncbi.nlm.nih.gov/pubmed/34477852
http://dx.doi.org/10.1001/jamanetworkopen.2021.23930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417764/
https://www.ncbi.nlm.nih.gov/pubmed/34477852
http://dx.doi.org/10.1001/jamanetworkopen.2021.23930

Ejemplares similares